PATIENT APP FOR
COLORECTAL CANCER
A comprehensive app that empowers patients with valuable insights and deeper understanding and knowledge of their disease. Co-funded and supported by the European Commission and close advocates.
European Union
FEATURES
medical records
on side effects of
the drug therapies
evidence based on
the mutation
the second opinion
trial matching
forum
DON'T MISS YOUR CHANCE AND
PRE-REGISTER FOR A FREE TRIAL TODAY!
Inspiration
This CRC Application was inspired by our co-founder Mark Rogers, who lost his own battle with Colorectal cancer in March 2022. Every year, nearly 2 million people are diagnosed with the disease and it is our team’s quest to deliver a valuable solution to anyone who has been touched by it.
Research
Arcella partnered with the innovative EU start-up to discover new combination therapy for Colorectal cancer while testing an existing blockbuster drug for Multiple Myeloma in a combination with nuclear export inhibitor, that showed effectiveness in destroying colorectal cancer cells from fresh patient-biopsy derived cells. Arcella is on a mission to continue our research to discover more novel and safe drug therapies to support cancer patients.
